Learn why Water for Injection (WFI) is a strategic utility in sterile drug manufacturing and how outsourcing WFI production ...

Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on clinical and operational progress for the fourth quarter and ...

Ooops... Something went wrong while loading this page.

Jazz Pharmaceuticals plc ( JAZZ) Q4 2025 Earnings Call February 24, 2026 4:30 PM EST Good day, and thank you for standing by. Welcome to the Jazz Pharmaceuticals Fourth Quarter 2025 Earnings ...

Roche RHHBY announced that the FDA has accepted its new drug application (NDA) for giredestrant, an investigational oral therapy, in combination with everolimus, for the treatment of adult patients ...

The Radioligand Therapy Market is projected to reach US$13 billion by 2030, growing at an estimated rate of 5%. Key drivers of this growth include the rising incidence of cancers such as prostate ...

US FDA accepts Pharmacyclics' Imbruvica sNDA filing and grants priority review status: Sunnyvale, California Tuesday, June 10, 2014, 18:00 Hrs [IST] The US Food and Drug Administr ...

Gunnison Copper (TSX:GCU) has emerged as America’s newest copper producer, marking its entry into the US copper market with a bold, focused strategy.

The two NFL teams that appeared in the Super Bowl -- the Patriots and the Seahawks -- each used last year's first-round pick ...

Summit Therapeutics (NASDAQ:SMMT) executives used the company’s Q4 and year-end 2025 earnings call to highlight continued ...

The San Francisco 49ers could go in a few different directions in the first three rounds of the draft this season. A lot will ...

CrossLink IGNITE Program -- Incentive initiative launched July 2025 and expanded, credited with accelerating ZYNRELEF ...